You choose, we deliver
If you are interested in this story, you might be interested in others from The Journal Gazette. Go to www.journalgazette.net/newsletter and pick the subjects you care most about. We'll deliver your customized daily news report at 3 a.m. Fort Wayne time, right to your email.

Health

  • Popular uterine surgery may heighten cancer risk
    The Food and Drug Administration is warning doctors against using a popular method to remove the uterus or uterine fibroids without open surgery because it can spread cancer cells.
  • 3rd chromosome 21 at work
    Symptoms of Down syndrome are produced by gene impairments across every chromosome, not just one, according to a study that may bring new understanding to the most common genetic cause of intellectual disability.
  • Heart attacks, strokes declining for diabetics
    In the midst of the diabetes epidemic, a glimmer of good news: Heart attacks, strokes and other complications from the disease are plummeting.
Advertisement

Spaniards suing German drug producer Gruenenthal

– Spaniards born with severe defects after their mothers used the drug Thalidomide during their pregnancies are suing its producer, the German company Gruenenthal Group.

Many of the children of the mothers who took the drug, a sedative prescribed between 1950 and 1960 to combat morning sickness, were born with abnormally short limbs and in some cases without any arms, legs or hips.

Now, 200 Spaniards are seeking compensation of $277 million from the company. The amount was calculated by multiplying 20,000 euros by the percentage point of each of the plaintiffs’ disability.

The Monday trial will last one day and a ruling is expected within a month.

Gruenenthal, who withdrew Thalidomide in 1961, has refused to accept liability, but last year it apologized to victims.

Advertisement